Andin Fosam1, Shanaz Sikder1, Brent S Abel1, Sri Harsha Tella1, Mary F Walter1, Andrea Mari2, Ranganath Muniyappa1. 1. Clinical Endocrine Section, Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 2. Institute of Neuroscience, National Research Council, Padova, Italy.
Abstract
BACKGROUND: African Americans (AAs) are at a higher risk for developing type 2 diabetes compared with non-Hispanic whites (NHWs). The causal role of β-cell glucose sensitivity (β-GS) and insulin clearance in hyperinsulinemia in AA adults is unclear. OBJECTIVE: Using a cross-sectional study design, we compared β-cell function and insulin clearance in nondiabetic AAs (n = 36) and NHWs (n = 47) after a mixed meal test (MMT). METHODS: Insulin secretion rate, glucose sensitivity, rate sensitivity, and insulin sensitivity during MMT were derived from a mathematical model. Levels of insulin-degrading enzyme (IDE) and carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1), key players in insulin clearance, were measured (by enzyme-linked immunosorbent assay) in hepatic cytosolic fractions from age-, sex-, and body mass index-matched AA and NHW cadaveric donors (n = 10). RESULTS: Fasting and mean postprandial plasma glucose levels were similar in both ethnic groups. AAs had significantly higher fasting and mean postprandial plasma insulin levels. However, fasting ISR, total insulin output, and insulin sensitivity during MMT were not different between the groups. β-GS and rate sensitivity were higher in AAs. Fasting and meal plasma insulin clearance were lower in AAs. Hepatic levels of IDE and CEACAM-1 were similar in AAs and NHWs. Hepatic IDE activity was significantly lower in AAs. CONCLUSIONS: In this study, lower insulin clearance contributes to higher plasma insulin levels in AAs. Reduced insulin clearance may be explained by lower IDE activity levels in AAs. Further confirmatory studies are needed to investigate diminished insulin clearance in AAs as a result of lower IDE activity levels. Published by Oxford University Press on behalf of the Endocrine Society 2020.
BACKGROUND: African Americans (AAs) are at a higher risk for developing type 2 diabetes compared with non-Hispanic whites (NHWs). The causal role of β-cell glucose sensitivity (β-GS) and insulin clearance in hyperinsulinemia in AA adults is unclear. OBJECTIVE: Using a cross-sectional study design, we compared β-cell function and insulin clearance in nondiabetic AAs (n = 36) and NHWs (n = 47) after a mixed meal test (MMT). METHODS:Insulin secretion rate, glucose sensitivity, rate sensitivity, and insulin sensitivity during MMT were derived from a mathematical model. Levels of insulin-degrading enzyme (IDE) and carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1), key players in insulin clearance, were measured (by enzyme-linked immunosorbent assay) in hepatic cytosolic fractions from age-, sex-, and body mass index-matched AA and NHW cadaveric donors (n = 10). RESULTS: Fasting and mean postprandial plasma glucose levels were similar in both ethnic groups. AAs had significantly higher fasting and mean postprandial plasma insulin levels. However, fasting ISR, total insulin output, and insulin sensitivity during MMT were not different between the groups. β-GS and rate sensitivity were higher in AAs. Fasting and meal plasma insulin clearance were lower in AAs. Hepatic levels of IDE and CEACAM-1 were similar in AAs and NHWs. Hepatic IDE activity was significantly lower in AAs. CONCLUSIONS: In this study, lower insulin clearance contributes to higher plasma insulin levels in AAs. Reduced insulin clearance may be explained by lower IDE activity levels in AAs. Further confirmatory studies are needed to investigate diminished insulin clearance in AAs as a result of lower IDE activity levels. Published by Oxford University Press on behalf of the Endocrine Society 2020.
Entities:
Keywords:
African Americans; insulin clearance; insulin degrading enzyme; β-cell function
Authors: Michael P Bancks; Kiarri Kershaw; April P Carson; Penny Gordon-Larsen; Pamela J Schreiner; Mercedes R Carnethon Journal: JAMA Date: 2017-12-26 Impact factor: 56.272
Authors: Olah Hakim; Oluwatoyosi Bello; Riccardo C Bonadonna; Cynthia Mohandas; Fariba Shojaee-Moradie; Nicola Jackson; Linda Boselli; Brandon Whitcher; Haris Shuaib; Kurt George M M Alberti; Janet L Peacock; Anne Margot Umpleby; Geoffrey Charles-Edwards; Stephanie A Amiel; Louise M Goff Journal: Diabetes Obes Metab Date: 2019-06-18 Impact factor: 6.577
Authors: Paula C Chandler-Laney; Radhika P Phadke; Wesley M Granger; José R Fernández; Julian A Muñoz; Chiara Dalla Man; Claudio Cobelli; Fernando Ovalle; Barbara A Gower Journal: Obesity (Silver Spring) Date: 2010-09-30 Impact factor: 5.002
Authors: S M Haffner; G Howard; E Mayer; R N Bergman; P J Savage; M Rewers; L Mykkänen; A J Karter; R Hamman; M F Saad Journal: Diabetes Date: 1997-01 Impact factor: 9.461
Authors: Jussi Pihlajamäki; Tanner Boes; Eun-Young Kim; Farrell Dearie; Brian W Kim; Joshua Schroeder; Edward Mun; Imad Nasser; Peter J Park; Antonio C Bianco; Allison B Goldfine; Mary Elizabeth Patti Journal: J Clin Endocrinol Metab Date: 2009-06-23 Impact factor: 5.958
Authors: C Christine Lee; Steven M Haffner; Lynne E Wagenknecht; Carlos Lorenzo; Jill M Norris; Richard N Bergman; Darko Stefanovski; Andrea M Anderson; Jerome I Rotter; Mark O Goodarzi; Anthony J Hanley Journal: Diabetes Care Date: 2012-12-05 Impact factor: 19.112
Authors: Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo Journal: Int J Mol Sci Date: 2021-02-24 Impact factor: 5.923
Authors: Neda Rasouli; Naji Younes; Kristina M Utzschneider; Silvio E Inzucchi; Ashok Balasubramanyam; Andrea L Cherrington; Faramarz Ismail-Beigi; Robert M Cohen; Darin E Olson; Ralph A DeFronzo; William H Herman; John M Lachin; Steven E Kahn Journal: Diabetes Care Date: 2020-12-17 Impact factor: 17.152
Authors: Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo Journal: Biomedicines Date: 2021-01-17
Authors: Alexis C Wood; Elizabeth T Jensen; Alain G Bertoni; Gautam Ramesh; Stephen S Rich; Jerome I Rotter; Yii-Der I Chen; Mark O Goodarzi Journal: Metabolites Date: 2021-06-26
Authors: Ana F Raimundo; Sofia Ferreira; Francisco A Tomás-Barberán; Claudia N Santos; Regina Menezes Journal: Nutrients Date: 2021-11-27 Impact factor: 5.717